Autopsy report · NCT04270916

Prevalence and Impact on QoL From Ototoxicity in Cancer Survivors

“due to COVID-19”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 46 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Sponsor

University of Nottingham

Sponsor type

University, hospital or other

Conditions

Hearing Loss, Sensorineural; Tinnitus, Subjective; Cancer; Chemotherapeutic Toxicity

Interventions

High frequency pure tone audiometry

Participants

46 (planned, not actual)

Sites

1

Countries

United Kingdom

Trials that died the same way

• BRIDGE Device for Treatment of Opioid Withdrawal
  “Due to COVID-19 pandemic” (93% match in meaning)
• Microbiological Evaluation of Single Versus Multiple Visits Regeneration Using MALDI-TOF Mass Spectrometry
  “due to the COVID-19 pandemic” (92% match in meaning)
• Virtual Reality for the Treatment of Chronic Low Back Pain
  “Due to the impact of COVID-19” (90% match in meaning)
• Yogurt Supplementation to Alter Bone Biomarkers, the Gut Microbiota and Inflammation in Older Adults
  “Due to the onset of the COVID-19 pandemic” (86% match in meaning)
• Effect of Global Postural Re-education in Idiopathic Scoliosis
  “Because of the COVID-19 pandemic” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.